Evidence map›Paper›PMID 38352515›Full record

ArticlebioRxiv : the preprint server for biology2024

Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer.

Luis Aparicio, Laura Crowley, John R Christin, Caroline J Laplaca, Hanina Hibshoosh, Raul Rabadan, Michael M Shen

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 3 countries.

Luis AparicioProgram for Mathematical Genomics, Columbia University Irving Medical Center, New York, NY.
Laura CrowleyDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY.
John R ChristinDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY.
Caroline J LaplacaDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY.
Hanina HibshooshDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY.
Raul RabadanProgram for Mathematical Genomics, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0001-7946-9255
Michael M ShenDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-4042-1657
Columbia University Irving Medical Center · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiationP01CA265768 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MICHAEL M. SHEN · 2022 to 2026
$13.4M
Towards a quantitative understanding of tumor evolutionR35CA253126 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Raul Rabadan · 2021 to 2026
$5.6M
A transdisciplinary approach for dissecting stem cell states in prostate cancerU01CA261822 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RABADAN, RAUL, SHEN, MICHAEL M. · 2021 to 2025
$3.1M
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell LymphomasU01CA243073 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PALOMERO, TERESA, RABADAN, RAUL · 2019 to 2023
$3.0M
Investigating lineage plasticity in castration-resistant prostate cancerR01CA251527 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHEN, MICHAEL M. · 2020 to 2024
$2.1M
Analysis of epithelial heterogeneity in prostate development and cancerR01CA238005 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHEN, MICHAEL M. · 2019 to 2023
$2.1M
Scanning Electron Microscope with 3ViewS10OD019974 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIANG, FENGXIA · 2016 to 2016
$1.1M
Epigenetic regulators of subtype plasticity in bladder cancerF32CA261152 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHRISTIN, JOHN ROBERT · 2021 to 2023
$210k
NCI NIH HHS F32 CA261152NCI NIH HHS P01 CA265768NCI NIH HHS P30 CA013696NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA238005NCI NIH HHS R01 CA251527NCI NIH HHS R35 CA253126NCI NIH HHS U01 CA243073NCI NIH HHS U01 CA261822NIH HHS S10 OD019974
6 · The paper itself

Abstract

Recent advances in single-cell RNA-sequencing (scRNA-seq) technology have facilitated studies of cell states and plasticity in tissue maintenance and cancer, including in the prostate. Here we present meta-analyses of multiple new and published scRNA-seq datasets to establish reference cell type classifications for the normal mouse and human prostate. Our analyses demonstrate transcriptomic similarities between epithelial cell states in the normal prostate, in the regressed prostate after androgen-deprivation, and in primary prostate tumors. During regression in the mouse prostate, all epithelial cells shift their expression profiles towards a proximal periurethral (PrU) state, demonstrating an androgen-dependent plasticity that is restored to normal during androgen restoration and regeneration. In the human prostate, we find progressive rewiring of transcriptional programs across epithelial cell types in benign prostate hyperplasia and treatment-naïve prostate cancer. Notably, we detect copy number variants predominantly within Luminal Acinar cells in prostate tumors, suggesting a bias in their cell type of origin, as well as a larger field of transcriptomic alterations in non-tumor cells. Finally, we observe that Luminal Acinar tumor cells in treatment-naïve prostate cancer display heterogeneous androgen receptor (AR) signaling activity, including a split between high-AR and low-AR profiles with similarity to PrU-like states. Taken together, our analyses of cellular heterogeneity and plasticity provide important translational insights into the origin and treatment response of prostate cancer.

Identifiers

PMID38352515
PMCPMC10862785
OpenAlexW4391873115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.